Cargando…
AB004. Evaluating differences in meaningful change in disease activity between different races and clinical subtypes affected by cutaneous lupus erythematosus
Cutaneous lupus erythematosus (CLE) has a profound impact on a patient’s quality of life (QoL), despite epidemiologic differences disease presentation. Disease activity, rather than damage, has a greater impact on QoL, and improvement in disease activity, defined by the Cutaneous Lupus Disease Area...
Autores principales: | Chakka, Srita, Krain, Rebecca, Ahmed, Sarah, Concha, Josef Symon S., Werth, Victoria P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033394/ http://dx.doi.org/10.21037/atm.2021.AB004 |
Ejemplares similares
-
AB005. Assessing meaningful changes in disease activity as clinical trial clinical efficacy measures for cutaneous lupus erythematosus
por: Chakka, Srita, et al.
Publicado: (2021) -
The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review
por: Chakka, Srita, et al.
Publicado: (2021) -
AB003. Increased CD69+ tissue-resident memory T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials
por: Zeidi, Majid, et al.
Publicado: (2021) -
AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
por: Concha, Josef Symon S., et al.
Publicado: (2021) -
AB021. Comparing the performance of two interferon-gamma release assays in autoimmune skin disease patients: a prospective study
por: Krain, Rebecca L., et al.
Publicado: (2021)